[Therapy of the chronic destructive, non-purulent cholangitis (primary biliary cirrhosis)].
D001379:Azathioprine / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D002761:Cholangitis / Q000150:complications / Q000188:drug therapy*; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000209:etiology; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy* / Q000209:etiology; D010024:Osteoporosis / Q000209:etiology; D010634:Phenobarbital / Q000627:therapeutic use; D011537:Pruritus / Q000188:drug therapy / Q000209:etiology; D014807:Vitamin D / Q000627:therapeutic use
D002792:Cholestyramine Resin; D014807:Vitamin D; D002994:Clofibrate; D001379:Azathioprine; D002118:Calcium; D010634:Phenobarbital
Die Therapie der chronisch destruierenden nicht eitrigen Cholangitis (primär biliäre Zirrhose)